Regulations.gov document
Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test…
Notice · FDA-2016-D-2561 · posted Feb 1, 2019
Key facts
| Document ID | FDA-2016-D-2561-0013 |
|---|---|
| Title | Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices; Guidance for Industry and Food and Drug Administration Staff; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2016-D-2561 |
| Posted | Feb 1, 2019 |
| Federal Register citation | 84 FR 1152 |
| FR document number | 2019-00569 |
| Comment period opens | Feb 1, 2019 |
| Effective date | Feb 1, 2019 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: